Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines

Open access
Davidson, Jaime A, Wilkinson, Alan, on behalf of the International Expert Panel on New-Onset Diabetes after Transplantation · 2004 · Diabetes Care

Abstract

New-onset diabetes and impaired glucose tolerance (IGT) are among the most serious metabolic complications of solid organ transplantation. Despite the importance of these conditions to the outcome of transplant recipients, their precise incidence is difficult to determine. This is due to the fact that there has been, until recently, no consensus regarding the definition of new-onset diabetes after transplantation. Thus different studies described in the literature have used a variety of diagnostic criteria (1). Consequently, the reported incidence of new-onset diabetes after transplantation has varied between 2 and 53%, whereas the prevalence of diabetes in the general population is estimated at ∼4% (2,3). Although new-onset diabetes has been recognized as a complication of transplantation for 50 years (4), the significance of the condition has been grossly underestimated. This is largely due to the fact that diabetes in transplant recipients was generally thought not to be associated with the micro- and macrovascular complications of diabetes in the nontransplant population (5). It is now clear, however, that the development of new-onset diabetes after transplantation is a major determinant of the increased cardiovascular morbidity and mortality seen in transplant recipients (6–8). Furthermore, studies indicate that the development of diabetes after transplantation has serious consequences for the patient, being associated with reduced graft function and patient survival and increased risk of graft loss (5,9,10). In addition, a recent analysis has revealed that the costs of developing new-onset diabetes after kidney transplantation are $12,000–$13,000 higher than for those with no diabetes by the end of the first year following transplantation. These costs rise to $19,000–$22,000 higher by the end of the second year (11). Studies suggest that a number of risk factors exist that may predict the development of new-onset diabetes in transplant patients. In …

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.3.805

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 260

Metadata

Authors
Davidson, J. A., Wilkinson, A., & Transplantation, O. B. O. T. I. E. P. O. N.-O. D. A.
Venue
Diabetes Care
Published
2004-03-01
Volume
27
Issue
3
Pages
805-812
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1974313161
Cited by
260
References
52
FWCI
7.78
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines. https://app.cochat.ai/papers/10.2337/diacare.27.3.805
The paper
Davidson, J. A., Wilkinson, A., & Transplantation, O. B. O. T. I. E. P. O. N.-O. D. A. (2004). New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines. Diabetes Care. https://doi.org/10.2337/diacare.27.3.805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.